Location: Boston, MA, USA
Start Date: 7/23/13
End Date: 7/26/13
Twitter #hashtag: #epicongress
BlueSEQ Discount Code: BLUESEQ (15% off)
Epigenetic drug discovery is exploding across the industry
And EpiCongress will place you right at the heart of the action…
With more epigenetics focused companies than anywhere else, the epicenter for epigenetic drug developers is returning to Boston this July 23 – 26.
The meeting has been designed in collaboration with thought leaders at GSK, EpiZyme, Constellation, Pfizer, Genentech, Celgene, Abbvie, Gilead, Acetylon, and many more. EpiCongress will not only help you to understand the basic mechanisms behind genome regulation and chromatin function. It will also address the most pressing clinical considerations to ensure the success of current and future candidates.
Hear from 50 expert speakers from across pharma, biotechs and research institutes presenting their most promising data. Capture the last 12 months of progress by hearing how epigenetic candidates have been performing across the board. And access the translational science with the potential to transform your drug discovery.
Please contact us at firstname.lastname@example.org if you have any information or opinions you’d like to share about this page.